XRAY DENTSPLY SIRONA Inc. DENTAL EQUIPMENT & SUPPLIES Best Medical Devices Stocks 2026 →

DENTSPLY SIRONA (XRAY) Stock: Buy, Sell, or Hold?

$9.76
+0.06 (+0.62%) ▲
5d: -8.36% 30d: +14.76% 90d: -15.72%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (64%)
Quality Score
43/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$8.61 – $9.77
Position: SLIGHTLY HIGH
Forward P/E & Valuation
7.8x FAIR
vs 7.4x historical avg
Wall Street Target
$11.03
+13.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$8.14 / $10.80
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
ℹī¸ NEUTRAL: XRAY is fairly priced but lacks strong directional signals. At 1.9% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Nov 6, 2026 at $9.39 · last confirmed Nov 10, 2026

Strength: 5.5/10

Get Alerted When XRAY Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$8.81
Based on -0.9% avg growth
INTRINSIC VALUE TODAY
$5.47
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.4x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: XRAY is currently trading at $9.76, which is considered slightly high relative to its 30-day fair value range of $8.61 to $9.77. The stock's valuation (Forward PE: 7.8) is in line with its historical norms (7.4). At these levels, the market is pricing in 1.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, XRAY is in a strong downtrend. Immediate support is located at $8.13, while resistance sits at $10.80.

Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $11.03 (+13.0%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $8.61 - $9.77
Company Quality Score 43/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 63.8%

Trading Range & Key Levels

30-Day Trading Range $8.61 - $9.77
Current vs Trading Range SLIGHTLY HIGH
Support Level $8.14
Resistance Level $10.80
Current Trend Strong Downtrend
Technical data as of Nov 11, 2026

Protect Your Profits

Holding XRAY? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Quantitative Signal Breakdown

  • NEUTRAL: Mixed technical signals (45/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($11.03)
  • NEUTRAL: Market pricing in 1.9% annual earnings growth - fairly valued
  • WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) 7.79
Wall Street Target $11.03 (+13.0%)
Revenue Growth (YoY) -7.5%
Earnings Growth (YoY) 15.2%
Profit Margin -3.4%
Valuation Premium vs History +1.9% premium
PE vs Historical 7.8 vs 7.4 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +1.9% (market-implied from PE analysis)
1-Year Target $9.95 (+2%)
2-Year Target $10.13 (+4%)
3-Year Target $10.33 (+6%)
3-Yr Target (if PE normalizes) (PE: 8→7) PE COMPRESSION $9.81 (+1%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 19.9, Growth: -5.9%) $20.73 (+112%)
Base: (SPY PE: 7.8, Growth: -5.9%) $8.13 (-17%)
Bear: (PE: 6.6, Growth: -5.9%) $6.91 (-29%)
Share XRAY Analysis

Share this live XRAY analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

Reddit StockTwits X / Twitter
bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (XRAY)

Bearish 2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 6, 2026
Daily AI digest
AI Retail Discussion Summary: Dentsply International (XRAY) reported Q3 earnings and revenues below estimates, causing a 14.4% stock drop.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 7:52 PM ET
Data refreshes hourly during market hours. Next update: 8:52 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
See Full Scanner Results »
Technical Signals Check

Is XRAY showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for XRAY.

Create Free Account

Already have an account? Log In

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ISRG
Intuitive Surgical Inc 		STRONG BUY
34 analysts 		$486 40 SELL
ALC
Alcon AG 		STRONG BUY
27 analysts 		$82 44 HOLD
RGEN
Repligen Corporation 		STRONG BUY
21 analysts 		$203 49 HOLD
WST
West Pharmaceutical Servâ€Ļ 		STRONG BUY
16 analysts 		$471 50 HOLD
RMD
ResMed Inc 		HOLD
20 analysts 		$264 58 HOLD
ISRG Intuitive Surgicaâ€Ļ
40 SELL
ALC Alcon AG
44 HOLD
RGEN Repligen Corporatâ€Ļ
49 HOLD
WST West Pharmaceuticâ€Ļ
50 HOLD
RMD ResMed Inc
58 HOLD

Advanced XRAY Option Strategies

Professional options setups generated by AI based on today's XRAY price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive XRAY Research Pages
XRAY Technical Chart XRAY Price Prediction XRAY Intrinsic Value DCF XRAY Earnings Date Why is XRAY Moving Today? XRAY Investment Advisor XRAY Fair Price Analyzer XRAY Options Chain XRAY Options Advisor XRAY Options Analysis XRAY Competitors
Part B: Tradestie Flagship Market Scanners
Today's Best Signals (XRAY) Sector Rotation Monitor AI Supply Chain Money Flow Gamma Squeeze (GEX) Scanner Undervalued Stocks Scanner Insider Cluster Buying Reddit & WSB Sentiment Tracker Backtested Stock Scanner
Compare XRAY with Peers
XRAY vs HSIC
Which one to buy?
XRAY vs COO
Which one to buy?
XRAY vs CHRW
Which one to buy?
XRAY vs TFX
Which one to buy?
XRAY vs EXPD
Which one to buy?
XRAY vs TFX
Winner: TFX
RGEN vs XRAY
CHRW vs XRAY
ATRC vs XRAY
LMAT vs XRAY
Winner: LMAT
MMSI vs XRAY
BLFS vs XRAY
XRAY vs NVST
XRAY vs AZTA
ABLV vs XRAY
Create New Comparison View All Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals